NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
최신 재무제표(Form-10K)에 따르면, NewGenIvf Group Ltd의 총 자산은 $21이며, 순손실입니다.
NIVF의 주요 재무 비율은 무엇인가요?
NewGenIvf Group Ltd의 유동비율은 4.2이고, 순이익률은 0, 주당 매출은 $0입니다.
NewGenIvf Group Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
NewGenIvf Group Ltd 주요 수익원은 In Vitro Fertilization Treatment이며, 최신 수익 발표에서 수익은 4,021,696입니다. 지역별로는 Kyrgyzstan이 NewGenIvf Group Ltd의 주요 시장이며, 수익은 3,123,593입니다.